Skip to main content

Table 2 Tomotherapy® plan characteristics

From: Light and shadows of a new technique: is photon total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one?

Pat Treatment session Plan Duration (min) N. rotations N. fractions Number of PTV sub-volumes used in optimization Number of region at risk used in optimization
#1 Upper Hemibody #1 U1 22.6 45.3 3 56 33
#1 U2 22.6 43.7 12 56 25
Lower Hemibody #1 L1 23.6 19 10 14 14
#1 L2 23.6 19 3 14 14
#2 Upper Hemibody #2 U1 27.1 56 8 59 27
#2 U2 28.9 56 8 68 28
Lower Hemibody #2 L1 40.0 50.1 3 45 35
#2 L2 40.0 50.1 13 46 34
#3 Upper Hemibody #3 U1 27.2 52.7 3 61 45
#3 U2 27.2 52.7 13 74 56
Lower Hemibody #3 L1 29.4 83.9 15 71 42